September 30, 2025
amar_ambani

Amar Ambani

Amar Ambani of IIFL has evaluated the Q1FY16 performance of seven stocks and given buy/ sell recommendations with price targets
Amar Ambani of IIFL has evaluated the Q1FY16 performance of seven stocks and given buy/ sell recommendations with price targets




The Stocks Talk Forum is also a repository of interesting articles and news items. Check it out now and contribute your share of news & views

Granules India (Q1 FY16) – BUY
CMP Rs115, Target Rs135, Upside 15.8%

  • Strong start to FY16 with margin beat on back of better operational efficiencies; PAT beats forecast at +18.6% yoy
  • Revenues below estimate at +11.2% yoy, down 2.4% qoq
  • Company expects sharp jump in FY17 capex as US business gains prominence
  • Raise estimates on robust Q1 and retain BUY with revised 9-12mth target of Rs135 (earlier Rs112)

Click here for the detailed report on the same.

TVS Motors (Q1 FY16) – Reduce
CMP Rs251, Target Rs230, Downside 5.3%

  • Net sales rise 13.7% yoy owing to 9.2% yoy growth in volumes and 4.1% jump in realizations, Sales were in line with our expectations
  • OPM at 6.2% was substantially below our estimates of 7%, while gross margins were higher by 70bps, 29bps yoy increase in overheads was disappointing
  • APAT was at Rs. 90cr was lower than estimates on weaker than expected operating performance
  • Growth in volumes was on account of 8.1% yoy increase in motorcycles and 18.6% yoy jump in three-wheeler volumes
  • We cut our estimates to factor in weaker than expected OPM trends in the past few quarters, Downgrade rating to Reduce from Accumulate with a revised price target of Rs230
  • Click here for the detailed report on the same.

    Lupin (Q1 FY16) – Accumulate
    CMP Rs1,672, Target Rs1,750, Upside 4.6%

    • Lupin revenues, margins largely in line; PAT beat on higher other income due to hedging gains
    • Acquires New Jersey based GAVIS Pharma for US$880mn, ~9x CY14 sales of US$96mn; deal establishes scale in derma and controlled substances
    • Earnings momentum to return in H2 FY16 with large launches but believe growth is already priced in at ~23x FY17E EPS; retain Accumulate

    Click here for the detailed report on the same.

    Dewan Housing Finance (Q1 FY16) – BUY
    CMP Rs498, Target Rs580, Upside 16.5%

    • AUMs registered strong growth of 27.4% yoy to Rs. 60,000cr
    • Spread intact at 2.6% as cost of borrowing benefits passed on to customers
    • Cost/income ratio decline with sweating of existing network
    • Asset quality performance strong with little downside risk
    • Retain BUY recommendation with 12-month target price of Rs580

    Click here for the detailed report on the same.

    Reliance Industries (Q1 FY16) – BUY
    CMP Rs1,025, Target Rs1,300, Upside 26.8%

    • Revenues at Rs. 65,817cr, lower by 31.7% yoy driven by sharp fall in crude oil prices causing weak refining and petchem segment sales
    • OPM improves by 633bps yoy but falls 126bps qoq; yoy increase was led by 462bps and 423bps rise in petchem and refining segment EBIT margins respectively, sequential fall was led by 134bps fall in refining EBIT margins
    • GRMs at US$10.4/bbl was higher than expectations, GRMs saw 19.5% yoy and 3% qoq increase and was substantially higher than the benchmarks
    • Shale gas revenues and EBIDTA declined qoq owing to fall in gas prices
    • PAT at Rs. 6,318cr was higher than our estimates owing to better than expected refining and petchem segment performance
    • Cut FY16 estimates but we maintain BUY rating with 2-year price target of Rs1,300

    Click here for the detailed report on the same.

    Bajaj Auto (Q1 FY16) – Accumulate
    CMP Rs2,497, Target Rs2,500, Upside 0.9%

    • Revenues at Rs. 5,613cr higher by 6.9% yoy; was lower than our estimates owing to lower than estimated export realizations
    • Blended realizations improved 4.3% yoy driven by 2.4% higher export realization (US$), rupee depreciation and 1.5% higher domestic realizations
    • Total volumes were higher by 2.5% yoy as 1.8% yoy decline in domestic volumes was more than offset by 7.8% yoy increase in export volumes. In terms of products, 2-W volumes were flat yoy while 3-W volumes surged 21.3% yoy
    • OPM at 20.3% was higher by 141bps yoy and 274bps qoq, OPM was in line with expectations but absolute operating profit was lower than expectations
    • APAT at Rs. 1,015cr was higher than our estimates due to lumpy other income
    • Maintain Accumulate rating with a 9-month price target of Rs2,500

    Click here for the detailed report on the same.

    Axis Bank (Q1 FY16) – BUY
    CMP Rs581, Target Rs670, Upside 15.5%

    • Loan growth was ahead of expectation at 23.5% yoy; retail and corporate loans grow strongly
    • Deposits mix stable; CASA + Retail TDs constitute 78.5%
    • NIM steady at 3.8%; could gradually decline from here
    • Fee growth retracted to 13% yoy; substantial treasury income and suppressed opex growth drive C/I ratio lower
    • Impaired assets addition was higher than expectation; however, it is likely to be lower yoy for the year
    • Risk-reward getting balanced, Retain BUY

    Click here for the detailed report on the same.

    2 thoughts on “Stocks To Buy & Sell After Q1FY16 Results: Amar Ambani Of IIFL

    1. Should buy jenburkt pharma. Relaxo after stellar results. Although relaxo is already priced in earning growth. Should wait for correction. .

    Leave a Reply to chandrashekhar dhage Cancel reply

    Your email address will not be published. Required fields are marked *